Genzyme Makes Moves to Fend Off Icahn
Friday, May 7, 2010 - 00:01
in Mathematics & Economics
The pharmaceutical company said it would buy back stock and spin off units to avoid a takeover by the investor Carl Icahn.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via